---
category: news
title: "Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer"
excerpt: "Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new study applying artificial intelligence (AI) enhanced protein design “QTY Code” technology."
publishedDateTime: 2022-06-30T13:03:00Z
originalUrl: "https://apnews.com/press-release/GlobeNewswire/technology-science-health-cancer-dfcd7a3926deb3ddb23937558ae96d83"
webUrl: "https://apnews.com/press-release/GlobeNewswire/technology-science-health-cancer-dfcd7a3926deb3ddb23937558ae96d83"
type: article
quality: 10
heat: 10
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "8vRBwmXL+5uPM8HxI5njKOsRLT60AttTm3cUjDg5bdoYIyb4XSHu/WwOu+zflSohD0Se/fUVfG/Z341ba0n85OqMBSZMZgvDpljb4BE2hacZ9o/JfXH4xrAElvYYScWn5n4rYni3sgtxlGM4uNT93YQstrQg5/1oyczmWLK4asr3FKHg/4+wd6JgWJhl1jK7V+qOytRAt9z2XlPqEFq1Ai/TY5EyHKKiqwC1hGFSYx3LLusQBADwuQmapFNZcjhIKeTW9LIP8edyE6ujflO3Vwg1ABB2cz8jVwzxzbILXJE2cBUFmgOy4o2gq0oqh8yGAj5C5GT892b9ElFpTNjgphTcBMWsAyqt51fDbILH7Ts=;CSwEOlMr/B6vJs3HbaNQ5Q=="
---

